52 related articles for article (PubMed ID: 22113592)
1. Combined hepatocellular-cholangiocarcinoma had poor outcomes after hepatectomy regardless of Allen and Lisa class or the predominance of intrahepatic cholangiocarcinoma cells within the tumor.
Ariizumi S; Kotera Y; Katagiri S; Nakano M; Yamamoto M
Ann Surg Oncol; 2012 May; 19(5):1628-36. PubMed ID: 22113592
[TBL] [Abstract][Full Text] [Related]
2. Histopathology-based immunoscore predicts recurrence for intrahepatic cholangiocarcinoma after hepatectomy.
Tian MX; Zhou YF; Qu WF; Liu WR; Jin L; Jiang XF; Wang H; Tao CY; Zhou PY; Fang Y; Ding ZB; Peng YF; Zhou J; Fan J; Shi YH
Cancer Immunol Immunother; 2019 Aug; 68(8):1369-1378. PubMed ID: 31338558
[TBL] [Abstract][Full Text] [Related]
3. Intrahepatic cholangiocarcinoma masked as fever of unknown origin.
Saidi RF; ReMine SG; Jacobs MJ
J Gastrointest Surg; 2004 Feb; 8(2):217-9. PubMed ID: 15036199
[TBL] [Abstract][Full Text] [Related]
4. Intrahepatic cholangiocarcinoma: how do hepatectomy outcomes compare to liver metastases and hepatocellular carcinoma?
Diggs LP; Fagenson AM; Putatunda V; Lau KN; Grandhi MS; Pitt HA
HPB (Oxford); 2023 Nov; 25(11):1420-1428. PubMed ID: 37573232
[TBL] [Abstract][Full Text] [Related]
5. Patients' prognosis of intrahepatic cholangiocarcinoma and combined hepatocellular-cholangiocarcinoma after resection.
Song P; Midorikawa Y; Nakayama H; Higaki T; Moriguchi M; Aramaki O; Yamazaki S; Aoki M; Teramoto K; Takayama T
Cancer Med; 2019 Oct; 8(13):5862-5871. PubMed ID: 31407490
[TBL] [Abstract][Full Text] [Related]
6. Whole-exome mutational and transcriptional landscapes of combined hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma reveal molecular diversity.
Liu ZH; Lian BF; Dong QZ; Sun H; Wei JW; Sheng YY; Li W; Li YX; Xie L; Liu L; Qin LX
Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt B):2360-2368. PubMed ID: 29408647
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic analysis of combined hepatocellular-cholangiocarcinoma according to the latest WHO classification.
Akiba J; Nakashima O; Hattori S; Tanikawa K; Takenaka M; Nakayama M; Kondo R; Nomura Y; Koura K; Ueda K; Sanada S; Naito Y; Yamaguchi R; Yano H
Am J Surg Pathol; 2013 Apr; 37(4):496-505. PubMed ID: 23388123
[TBL] [Abstract][Full Text] [Related]
8. Component prediction in combined hepatocellular carcinoma-cholangiocarcinoma: habitat imaging and its biologic underpinnings.
Xiao Y; Huang P; Zhang Y; Lu X; Zhou C; Wu F; Wang Y; Zeng M; Yang C
Abdom Radiol (NY); 2024 Apr; 49(4):1063-1073. PubMed ID: 38315194
[TBL] [Abstract][Full Text] [Related]
9. Anatomical liver resection improves surgical outcomes for combined hepatocellular-cholangiocarcinoma: A propensity score matched study.
Wang WQ; Li J; Liang BY; Lv X; Zhu RH; Wang JL; Huang ZY; Yang SH; Zhang EL
Front Oncol; 2022; 12():980736. PubMed ID: 36059669
[TBL] [Abstract][Full Text] [Related]
10. Combined Hepatocellular-Cholangiocarcinoma: An Update on Pathology and Diagnostic Approach.
Choi JH; Ro JY
Biomedicines; 2022 Jul; 10(8):. PubMed ID: 36009374
[TBL] [Abstract][Full Text] [Related]
11. Management of combined hepatocellular carcinoma-cholangiocarcinoma.
Yang JD; Roberts LR
Curr Hepatol Rep; 2018 Dec; 17(4):385-391. PubMed ID: 35990187
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of nomogram to predict very early recurrence of combined hepatocellular-cholangiocarcinoma after hepatic resection: a multi-institutional study.
Wu Y; Liu H; Zeng J; Chen Y; Fang G; Zhang J; Zhou W; Zeng Y; Liu J
World J Surg Oncol; 2022 Feb; 20(1):60. PubMed ID: 35227269
[TBL] [Abstract][Full Text] [Related]
13. Elevated neutrophil-to-lymphocyte ratio and predominance of intrahepatic cholangiocarcinoma prediction of poor hepatectomy outcomes in patients with combined hepatocellular-cholangiocarcinoma.
Chiu TJ; Chen YJ; Kuo FY; Chen YY
PLoS One; 2020; 15(12):e0240791. PubMed ID: 33306714
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological features and recurrence patterns of combined hepatocellular-cholangiocarcinoma.
Ishii T; Ito T; Sumiyoshi S; Ogiso S; Fukumitsu K; Seo S; Taura K; Uemoto S
World J Surg Oncol; 2020 Dec; 18(1):319. PubMed ID: 33276780
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant Transarterial chemoembolization does not influence recurrence-free or overall survival in patients with combined hepatocellular carcinoma and Cholangiocarcinoma after curative resection: a propensity score matching analysis.
Liu WR; Tian MX; Tao CY; Tang Z; Zhou YF; Song SS; Jiang XF; Wang H; Zhou PY; Qu WF; Fang Y; Ding ZB; Zhou J; Fan J; Shi YH
BMC Cancer; 2020 Jul; 20(1):642. PubMed ID: 32650743
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Imaging and Clinically Relevant Features of Combined Hepatocellular Carcinoma and Cholangiocarcinoma with Hepatocellular Carcinoma.
Huang X; Li Y; Long L
Med Sci Monit; 2019 Nov; 25():8595-8601. PubMed ID: 31726461
[TBL] [Abstract][Full Text] [Related]
17. Combined hepatocellular-cholangiocarcinoma: An analysis of clinicopathological characteristics after surgery.
Zhang H; Yu X; Xu J; Li J; Zhou Y
Medicine (Baltimore); 2019 Sep; 98(38):e17102. PubMed ID: 31567946
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a prognostic score predicting recurrence in resected combined hepatocellular cholangiocarcinoma.
Tian MX; Luo LP; Liu WR; Deng W; Yin JC; Jin L; Jiang XF; Zhou YF; Qu WF; Tang Z; Wang H; Tao CY; Fang Y; Qiu SJ; Zhou J; Liu JF; Fan J; Shi YH
Cancer Manag Res; 2019; 11():5187-5195. PubMed ID: 31239773
[No Abstract] [Full Text] [Related]
19. Adrenal metastasis in sequentially developed combined hepatocellular carcinoma-cholangiocarcinoma: A case report.
Nugroho A; Lee KW; Lee KB; Kim HS; Kim H; Yi NJ; Suh KS
Ann Hepatobiliary Pancreat Surg; 2018 Aug; 22(3):287-291. PubMed ID: 30215052
[TBL] [Abstract][Full Text] [Related]
20. A Novel Risk prediction Model for Patients with Combined Hepatocellular-Cholangiocarcinoma.
Tian MX; He WJ; Liu WR; Yin JC; Jin L; Tang Z; Jiang XF; Wang H; Zhou PY; Tao CY; Ding ZB; Peng YF; Dai Z; Qiu SJ; Zhou J; Fan J; Shi YH
J Cancer; 2018; 9(6):1025-1032. PubMed ID: 29581782
[No Abstract] [Full Text] [Related]
[Next] [New Search]
